澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Osteopore

0.004

0.000

成交量：80.00萬

成交額：3,200

市值：277.44萬

市盈率：-0.27

高：0.004

開：0.004

低：0.004

收：0.004

52周最高：0.029

52周最低：0.004

股本：6.94億

流通股本：2.08億

量比：0.42

換手率：0.38%

股息：- -

股息率：- -

每股收益(TTM):-0.015

每股收益(LYR):-0.020

淨資產收益率：-487.52%

總資產收益率：-57.24%

市淨率：-1.54

市盈率(LYR):-0.20

資料載入中...

總覽公司新聞公告

Osteopore攜手Zimmer Biomet，其顱頜面產品成功獲准進入沙特阿拉伯市場

Osteopore Ltd 啓動單側唇裂患者鼻旁骨填充臨床研究

Osteopore獲海南藥監局批准生產骨科定製醫療器械

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/OSX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OSX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","market":"AU","secType":"STK","nameCN":"Osteopore","latestPrice":0.004,"timestamp":1789107120000,"preClose":0.004,"halted":0,"volume":800000,"delay":0,"changeRate":0,"nameEN":"Osteopore","floatShares":207851789,"shares":693592914,"eps":-0.015,"marketStatus":"休市中","change":0,"latestTime":"09-11 16:12:00 AEST","open":0.004,"high":0.004,"low":0.004,"amount":3200,"amplitude":0,"askPrice":0.005,"askSize":7172064,"bidPrice":0.004,"bidSize":1675054,"shortable":3,"etf":0,"ttmEps":-0.015,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.004,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":0.4221994140894784,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OSX.AU","preClose":0.005,"auctionPrice":0.004,"auctionVolume":1149250,"auction":3,"marketStatus":"盘后竞价","timestamp":1788933614393}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","floatShares":207851789,"roa":"-57.24%","roe":"-487.52%","lyrEps":-0.019761,"volumeRatio":0.4221994140894784,"shares":693592914,"dividePrice":0,"high":0.004,"amplitude":0,"preClose":0.004,"low":0.004,"week52Low":0.004,"pbRate":"-1.54","psRate":"0.95","week52High":0.029,"institutionHeld":0,"latestPrice":0.004,"committee":-0.621333,"eps":-0.015,"divideRate":0,"volume":800000,"delay":0,"ttmEps":-0.015,"open":0.004,"prevYearClose":0.006,"prevWeekClose":0.004,"prevMonthClose":0.004,"prevQuarterClose":0.004,"fiveDayClose":0.004,"twentyDayClose":0.004,"sixtyDayClose":0.004,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"OSX.AU","defaultRemindTime":1708642800000,"type":"split","dateTimestamp":1708606800000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148865604","title":"Osteopore攜手Zimmer Biomet，其顱頜面產品成功獲准進入沙特阿拉伯市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1148865604","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148865604?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 06:35","pubTimestamp":1783377342,"startTime":"0","endTime":"0","summary":"Osteopore已成功为其颅颌面产品获得沙特阿拉伯市场的准入资格。此次市场进入将通过与国际医疗技术巨头Zimmer Biomet建立的合作伙伴关系进行分销。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159500944","title":"Osteopore Ltd 啓動單側唇裂患者鼻旁骨填充臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1159500944","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159500944?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 07:10","pubTimestamp":1780355415,"startTime":"0","endTime":"0","summary":"Osteopore Ltd 宣布，已正式启动一项针对单侧唇裂患者的鼻旁骨填充临床研究。这项研究旨在评估公司专有骨组织工程支架在修复相关面部骨骼缺陷中的安全性与有效性，标志着其在颅颌面修复应用领域迈出了关键一步。该临床研究的推进，有望为这类患者群体提供新的、更优的再生医学治疗选择，同时也可能为公司的核心产品线开辟重要的临床应用市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121972246","title":"Osteopore獲海南藥監局批准生產骨科定製醫療器械","url":"https://stock-news.laohu8.com/highlight/detail?id=1121972246","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121972246?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 09:31","pubTimestamp":1779759062,"startTime":"0","endTime":"0","summary":"5月26日（路透社）—— Osteopore有限公司宣布，其骨科定制医疗器械已获得海南省药品监督管理局的批准。这一进展标志着该公司在特定医疗设备领域的监管准入取得了关键突破，为其相关产品在中国市场的应用铺平了道路。\n该批准涉及为患者量身定制的骨科医疗装置，此类产品通常用于复杂的骨骼修复与重建手术。获得地方监管机构的许可是医疗器械公司商业化进程中的重要一步。\n更多关于该公司的信息，请参考其股票代码：OSX.AX。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}